Background An elevated serum remnant lipoprotein cholesterol (RLP-C)/ triglyceride (TG) ratio has not been evaluated as an index of familial type III hyperlipidaemia defined by the presence of b-VLDL and apolipoprotein (Apo) E2/2 phenotype in the Japanese hyperlipidaemic population.
Introduction
Familial type III hyperlipoproteinaemia (familial dysbetalipoproteinaemia, type III) is a hyperlipidaemia encountered as familial hypercholesterolaemia (FH), characterized by cholesterol ester-rich remnant accumulation and typically associated with an apolipoprotein (Apo) E2/2 phenotype, indicative of the presence of b-VLDL. 1--3 Previous studies have reported that a serum remnant lipoprotein cholesterol (RLP-C)/triglyceride (TG) ratio 40. 23 has been highly correlated with the presence of b-VLDL ('broad-beta band'detected by agarose gel electrophoresis) in subjects with type III hyper-lipidaemia. 4, 5 Although the VLDL-cholesterol (VLDL-C)/TG ratio has been used as an alternative marker for the detection of b-VLDL, 6 it has been demonstrated that the RLP-C/TG ratio was shown to be a better marker for this purpose. 5 Recently Todo et al. 7 demonstrated that the measurement of the serum Apo E/Apo CIII ratio could be used as an alternative marker of Apo E2/2 phenotype in Japanese hyperlipidaemic individuals.
In the present study, we determined serum lipid and lipoprotein concentrations and their ratios in a cohort of Japanese hyperlipidaemic individuals, in conjunction with measurement of currently accepted markers such as electrophoretic broad-beta band, 8 Apo E/Apo CIII ratio 7 and Apo E phenotype. 9 The purpose of this study was to identify familial type III subjects in the Japanese hyperlipidaemic population by using RLP-C concentration and RLP-C/TG ratio, in conjunction with other markers.
Procedures

Study subjects
The study subjects were 514 hyperlipidaemics (200 men and 314 women, mean age of 58 years [range 18--79 years]) selected from a population of 25,080 individuals who received a routine health checkup in Urawa city, Japan. Blood was collected after the subjects were fasted overnight. All selected subjects had total cholesterol (TC) 46.22 mmol/L and TG of 2.26--9.04 mmol/L. The control group consisted of 194 subjects with TC o5.18 mmol/L and TG o 2.26 mmol/ L and of the age and gender matched with the study group. This study was approved by the ethical committee of Urawa Medical Association.
Lipid and lipoprotein analyses
Serum TC and TG were measured by Center for Disease Control (CDC) standardized enzymatic methods. HDL-cholesterol (HDL-C) was measured by using a homogeneous assay kit (Daiichi Chemicals, Tokyo, Japan). Lipoprotein(a) (Lp(a)) was measured with an immunoturbidimetric assay kit (Denka-seiken, Tokyo, Japan) and Hitachi 707 automated chemistry analyser. RLP-C was measured by an RLP-C assay kit (JIMRO, Takasaki, Japan). 10 Brie£y, the RLP-C was determined with 5mL of serum using a speci¢c immunoa⁄nity mixed gel containing monoclonal anti Apo B-100 (JI-H) and anti Apo A-I (H-2). Serum samples were incubated with the immunoa⁄nity gel for 2 h with mild mixing. Cholesterol concentrations in the RLP fractions (unbound fraction to the immunoa⁄nity gel) were determined by a sensitive cholesterol assay (Determiner L-TC; Kyowa Medex, Tokyo). Lipoproteins were separated and measured with an AGE Cholesterol Pro¢le-15 kit (Helena Laboratories, Beaumont,TX, USA) together with PAGA (LipoPhor by Quantimetrix, Los Angeles, CA, USA). Apo E phenotyping was performed by isoelectric forcusing gel electrophoresis (Phenotyping Apo E, JOKOH,Tokyo, Japan) in cases with a broadbeta band positive by lipoprotein pro¢le analysis of the whole serum.
Statistical analysis
Quantitative values are reported as mean7SD. Statistical signi¢cance of the di¡erences was determined by unpaired t-test. Associations between variables are presented as Pearson's correlation coe⁄cient. Po0.05 was considered to be signi¢cant. Sensitivity, speci¢city and receiver-operating characteristic (ROC) curve analyses were used to compare test parameters.
Results
Characteristics of lipid and lipoprotein profiles in study subjects
As shown in Table 1 , 514 cases were selected at serum concentrations of TC 46.22 mmol/L and TG of 2.26--9.04 mmol/L. These hyperlipidaemic cases comprised 2.0% of the original population. Hyperlipidaemia was 1.6 times more prevalent in men than in women. The hyperlipidaemia in these 514 cases re£ected mostly, if not totally, type II b with either familial or secondary dysfunction of lipid metabolism. The frequency of RLP-C 40.19 mmol/L (upper cut-o¡ value for healthy controls) 11 was 91.8%. The frequency of broad-beta band positivity was 6.0% (31/514), which was indicative of the presence of b-VLDL.
Lipid and lipoprotein profiles of subjects with TC 46.22 and 2.26o TG o9.04 mmol/L The median concentrations of TC and TG were 6.76 and 2.75 mmol/L, respectively, in this study group ( Table 2) . The median of HDL-C was 1.35 mmol/L and was considered to be within the normal range. Median RLP-C concentration (0.30 mmol/L) was signi¢cantly higher than the upper cut-o¡ concentration for healthy controls (0.19 mmol/L) in association with signi¢cantly higher Apo CIII (0.154 g/L), but Apo E (0.066 g/L) was mostly within the normal range. Median Lp(a) was within the normal range. RLP-C/TG ratio and RLP-C/HDL-C ratio were slightly below cut-o¡ concentrations.
Comparison of lipid and lipoprotein profiles in cases with and without broad-beta band positive
The presence of electrophoretic broad-beta band has been used for detection of remnant lipoproteins especially for b-VLDL. 8 Only 31 of 514 (6.0%) hyperlipidaemic subjects were detected as having a broad-beta band in this study group. The presence of broad-beta band was signi¢cantly more frequent in men (8.5%; 17 of 200) than in women (4.5%; 14 of 314; Po0.001). The Apo E phenotypes among the subjects with broad-beta band positive were: E3/2, 22.6%; E3/3,51.6%; E3/5,3.2%; E4/2, 3.2%; E4/3, 16.1%; E4/4, 3.2 ( Table 1 ). The frequency of the E2 allele was signi¢cantly higher in this broad-beta positive group, compared with the overall Japanese population as previously reported (25.8% versus 12.2%, Po0.001). 12,13 TG, RLP-C, Apo CIII and Apo E were all shown to be signi¢cantly higher in cases with broad-beta band positive, but TC, HDL-C and Lp(a) were not signi¢cantly di¡erent between the broad-beta positive and negative cases. RLP-C/TG ratio and RLP-C/ HDL-C ratio were also signi¢cantly higher in cases with broad-beta band positive than negative (0.15 versus 0.11; 0.58 versus 0.23, Po 0.0001) ( Table 3 ).
Receiver-operating characteristic curve analysis of specificity and sensitivity of broad-beta positive lipid profile
A close association was found between the cases with broad-beta band positive (n ¼ 31) and TG, Apo E, Apo CIII and RLP-C, but not Lp(a), TC or HDL-C ( Figure 1) . These results suggested that the presence of broad-beta band was strongly associated with the presence of remnant lipoproteins.
Relationship between RLP-C, TG and RLP-C/TG ratio
The correlation coe⁄cient between RLP-C and TG was 0.87 in this study group, which is very similar to the cases previously reported 14, 15 (Figure 2 ). The average RLP-C/TG ratio in the control group with TG o2.26 mmol/L was 0.027, while the ratio in the hyperlipidaemic subjects with TG 42.26 mmol/L was 0.074 (Po0.001). But no correlation was found between RLP-C/ TG ratio and TG concentration (R 2 ¼0.147) (Figure 3a) . RLP-C/TG ratio versus RLP-C showed a close correlation (R 2 ¼0.886) as shown in Figure 3b and the RLP-C/TG ratio greater than 0.23 was observed in three cases with RLP-C 40.78 mmol/L.
Relationship between Apo E and Apo CIII
The correlation coe⁄cient between Apo E and Apo CIII ratio was 0.51 in this study group (Figure 4) , which was similar to the cases without phenotype E2/2 as previously reported. 7 No cases with Apo E/Apo CIII ratio greater than 1.0, an alternative marker for Apo E2/2 phenotype, were detected in these 514 cases.
Evaluation of the three cases carrying b-VLDL
Thirty-one subjects with broad-beta band were evaluated for familial hyperlipidaemia according to the parameters tested. Three cases (one case with Apo E2/3, two cases with Apo E3/3) were detected as having RLP-C/ TG ratio above 0.23, but none of the three was Apo E2/ 2 or characteristic of familial Type III. Apo E/Apo CIII ratio in the three cases was 0.42, 0.50 and 0.60, namely less than1.0. 7 Therefore, these three cases were diagnosed to be not familial type III, but probably heterozygous FH.
Discussion
RLP-C assay has been used as a reliable marker to identify the risk factors for coronary artery disease. 16 In particular, high serum RLP-C concentrations such as 40.78 mmol/L is known to be strongly associated with familial type III hyperlipidaemia. 4, 5 Recently, in patients with FH and familial combined hyperlipidaemia (FCHL), high serum RLP-C concentrations were reported. 17, 18 FH has been mostly recognized by a high serum LDL concentration, but a high remnant lipoprotein concentration (IDL) was also reported. 19 Furthermore, FCHL patients are known to have small dense LDL, hyper-Apo B and high serum RLP-C concentrations. 18 In view of these ¢ndings, we were interested in identifying familial type III hyperlipidaemia by using not only RLP-C concentration but RLP-C/TG ratio, indicative of the presence of b-VLDL, in comparison with other accepted markers for familial type III in a large Japanese population who received health checkup. Homozygous FH is very rare and usually found with a very high cholesterol concentration above 13.0 mmol/ L, but heterozygous FH is more prevalent, approximately one in 500, showing serum cholesterol concentrations between 6.48 and 13.0 mmol/L, but TG concentrations are often normal in the Japanese population. Recently, FH patients with an elevated serum TG concentration have been reported to exhibit signi¢cantly elevated RLP-C concentrations in Caucasians. 17 Familial Type III is also found very rarely, one in 10,000, but Apo E2/2 carriers are more prevalent, one in100--500 in the general population. The most prevalent hyperlipidaemia (approximately one in 100) is FCHL, showing elevated concentrations of both serum TG and TC, as ¢rst reported by Goldstein et al. 20 in 1973. FCHL presents high similarity with type IIb and metabolic syndrome, but having genetic defects as coronary heart disease (CHD) risk which require di¡erent therapeutic treatments.
We have previously reported the ratio of RLP-C/TG in relation to particle size for RLP 21 and as an alternative index to VLDL-C/TG ratio. 6 The RLP particles rich in cholesterol relative to TG were usually smaller in size like IDL or large LDL and seem to be more atherogenic than TG-rich larger particles such as chylomicron (CM) remnants or large VLDL. RLP from familial type III hyperlipidaemia (b-VLDL) was shown to be of smaller VLDL or IDL size, and the RLP from FH were of IDL or large LDL size. 20 The RLP-C/TG ratio of smaller particles was shown to be much higher than that of larger RLP particles. 20 Therefore, in this study we were interested in a relationship between higher RLP-C/TG ratio (or smaller particle size) and inherited disorder such as familial type III, FCHL and FH. RLP with a high RLP-C/ TG ratio or RLP of IDL size may be originated mostly from endogenous remnants (Apo B-100 carrying VLDL remnants) rather than exogenous remnants (Apo B-48 carrying CM remnants). Thus, familial hyperlipidaemia in general may be more closely related withVLDL remnants than CM remnants.
We found three cases of RLP-C/TG ratio above 0.23 among 514 hyperlipidaemics in an average Japanese population of 25,080 individuals who came for health checkup in an area of 50 miles north of Tokyo. These three cases were not Apo E2/2, but E2/3 (one case) and 3/3 (two cases). Also the cases with other markers for familial type III, such as Apo E/Apo CIII ratio greater than 1.0, 7 were not detected in these hyperlipidaemic cases. Therefore, we could not ¢nd any typical familial type III in this study population, but found the cases carrying b-VLDL. The frequency of familial type III detected in this study seemed to be less than in previous studies in Japan. 12, 13 We did not analyse the genetic disorder of LDL receptor for the three cases, but these three cases seemed to be heterozygous FH as judged by TC concentrations (6.4--8.13 mmol/L),TG concentrations (3.4--8.20 mmol/L) and Apo E/Apo CIII ratios (0.42--0.60). We also found a high frequency of RLP-C/ TG ratio above 0.12 which is a much higher ratio than in normal controls and indicative of FCHL cases. These cases have been reported by Masuoka et al. 22, 23 to be highly associated with high coronary stenosis index (CSI; RLP-C/HDL-C ratio).
Type III dyslipoproteinaemia de¢ned by VLDL-C/TG ratio 40.69 with plasma TG 41.69 mmol/L is very similar to that de¢ned by RLP-C/TG ratio 40.23, indicating the presence of b-VLDL. 5 It has been reported by Hopkins et al. 6 that, in heterozygous FH genetically linked to the LDL receptor locus, a strong interaction was observed between the presence of FH and a single Apo E2 allele, resulting in a markedly increased prevalence of type III dyslipoproteinaemia together with FH. Our present knowledge suggests that b-VLDL is highly atherogenic with or without Apo E2/2 phenotype. 6 Therefore, the detection of cases with RLP-C/TG ratio greater than 0.23 in hyperlipidaemic subjects might be meaningful for diagnosis and prevention of the increased risk for premature CHD, irrespective of the presence of Apo E2/2.
In conclusion, the detection of b-VLDL using RLP-C/ TG ratio might be useful for ¢nding atherogenic conditions such as type III dyslipoproteinaemia with or without Apo E2/2. Figure 4 Correlation between Apo CIII (mg/dL) and Apo E (mg/dL). None of the 514 cases was found to have an Apo E/Apo CIII ratio greater than 1.0, which indicates Apo E2/2 or the characteristics of familial type III. Three squares were the cases with RLP-C/ TG ratio greater than 023
